Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Validation of ColonAiQ (a Blood-based Assay Targeting Circulating Tumor DNA Methylation) for Colorectal Cancer Detection

NCT06347887 is registered in ClinicalTrials.gov with Singlera Genomics Inc. as lead sponsor.

NCT NCT06347887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06347887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Validation of ColonAiQ (a Blood-based Assay Targeting Circulating Tumor DNA Methylation) for Colorectal Cancer Detection
Lead sponsor
Singlera Genomics Inc.
Phase
Observational
Overall status
Completed
Start date
May 31, 2021
Completion date
January 16, 2024
Enrollment
1,965 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer